RecruitingNCT04635891
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Studying Facioscapulohumeral dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Kansas Medical Center
- Principal Investigator
- Jeffrey Statland, MDUniversity of Kansas Medical Center
- Enrollment
- 450 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2028
Study locations (20)
- David Geffen School of Medicine at UCLA, Los Angeles, California, United States
- Neuromuscular Disorders Program at Stanford University School of Medicine, Stanford, California, United States
- University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- Univeristy of Florida Gainesville, Gainesville, Florida, United States
- University of Iowa, Iowa City, Iowa, United States
- Univeristy of Kansas Medical Center, Kansas City, Kansas, United States
- Kennedy Krieger Institute, Baltimore, Maryland, United States
- University of Rochester Medical Center, Rochester, New York, United States
- The Ohio State University Medical Center, Columbus, Ohio, United States
- Austin Neuromuscular Center, Austin, Texas, United States
- Univeristy of Texas Southwestern Medical Center, Dallas, Texas, United States
- University of Texas Health San Antonio, San Antonio, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- University of Washington Medical Center, Seattle, Washington, United States
- +5 more locations on ClinicalTrials.gov
Collaborators
FSHD Society, Inc. · Friends Research Institute, Inc. · University of Rochester · University of Nevada, Reno · FSHD Canada · Avidity Biosciences, Inc. · AMRA Medical · Seattle Children's Hospital · Dyne Therapeutics · Hoffmann-La Roche · Springbok Analytics
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04635891 on ClinicalTrials.govOther trials for Facioscapulohumeral dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07086521Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)Restem, LLC.
- RECRUITINGPHASE3NCT07038200A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHDAvidity Biosciences, Inc.
- RECRUITINGPHASE1, PHASE2NCT06907875A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular DystrophyEpicrispr Biotechnologies, Inc.
- ENROLLING BY INVITATIONNCT07164937Imaging and Gait Analysis in FSHD PatientsFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNCT06911190Ten Year Follow-up in FSHD: the FOCUS 3 StudyRadboud University Medical Center
- RECRUITINGNCT07409142BetterLife FSHD: A Patient-driven Health and Research PlatformFSHD Society
- ENROLLING BY INVITATIONPHASE2NCT06547216Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)Avidity Biosciences, Inc.
- RECRUITINGNANCT06600308Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular DystrophiesCentre Hospitalier Universitaire Dijon